Inside EU Health

Inside EU Health: MEPs call for ring-fenced health funding; OECD urges better use of resources in cancer care; four in ten cancers worldwide are preventable, says WHO

MEPs call for dedicated cancer funding in EU’s long-term budget; OECD urges faster access and better use of resources in cancer care; four in ten cancers worldwide are preventable, says WHO

Cancer

Four in ten cancers worldwide are preventable, says WHO

In 2022, an estimated 7.1 million of 18.7 million new adult cancer cases were attributable to modifiable risk factors

MFF

MEPs call for dedicated cancer funding in EU’s long-term budget

The European Cancer Organisation (ECO) has a clear message for the European Parliament: Europe’s Beating Cancer Plan is working and its future must now be secured. ECO warns that hard-won progress is at risk as negotiations begin on the EU’s next long-term budget for 2028–2034, with concerns

Cancer

OECD urges faster access and better use of resources in cancer care

Europe must improve access, reduce low-value care and put patients at the centre of cancer services, according to a new OECD report

Inside EU Health

Inside EU Health: CMA trilogue; cardiovascular strategy; EMA medicines approval; healthcare accessibility

Critical Medicines Act negotiations begin; prevention takes centre stage in opening EU cardiovascular health report; EMA recommends approval of six medicines, expands indications for nine; Eurostat figures show wide gaps in healthcare accessibility across EU

Critical Medicines Act

Critical Medicines Act negotiations begin, with urgency stressed by co-legislators

The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday (2 February) evening, with discussions described as constructive. Co-legislators reiterated both their readiness to move forward and the urgency of the file, given ongoing concerns around the EU’s security of medicine supply. Earlier that afternoon, addressing

Cardiovascular disease

Prevention takes centre stage in EU cardiovascular health report

The European Parliament’s first debate on MEP Romana Jerković's (S&D, Croatia) draft own-initiative report for an EU cardiovascular disease (CVD) strategy revealed broad support for action, alongside early differences of emphasis rather than open disagreement. Presenting her draft, rapporteur Jerković underlined the urgency of the

EMA

EMA recommends approval of six medicines, expands indications for nine

EMA recommended six medicines for approval at its meeting and extended the therapeutic indications of nine medicines.

Inside EU Health

Inside EU Health: EPP request pause on wastewater law; S&D urges Várhelyi to back €90 billion for health in next MFF; infant formula recall; ERC backs bench-to-clinic innovations; WHO inaugurates Cyprus office

Várhelyi sympathetic to one-year ‘stop-the-clock’ pause; S&D urges Várhelyi to back €90 billion for health in next MFF; ECDC warns of toxin-containing infant formula; ERC backs bench-to-clinic innovations; WHO/Europe establishes Cyprus office

EU-India

EU-India free trade deal will slash tariffs for medicines and medical devices

The EU and India have agreed a free trade deal that promises to significantly cut tariffs on medicines and medical devices

Inside EU Health

Inside EU Health: EU-India free trade deal will slash tariffs for medicines and medical devices; six countries in the WHO/Europe region lose measles-free status

EU-India free trade deal will slash tariffs for medicines and medical; six countries in the WHO/Europe region lose measles-free status

Inside EU Health

Inside EU Health: WHO defends itself from US slurs; pilot targets 70-day clinical trial approvals; less than 1% of research spent on key women’s health issues

WHO defends itself against US accusations; FAST-EU pilot targets 70-day clinical trial approvals; less than 1% of research funding goes to key women’s health conditions

Inside EU Health

Inside EU Health: EFPIA raises its CMA concerns; Élysée dismisses Trump 'Fake News'; EU funds €147 million for health research and investment in Africa

EFPIA raises its CMA concerns; Élysée dismisses Trump’s Davos claim on medicine prices as 'Fake News'; EU funds €147 million for health research and investment in Africa

Inside EU Health

Inside EU Health: WHO to consider US payment arrears; IHI unveils first applicant-driven projects; improvement in unmet medical needs of children

WHO Executive Board will consider US payment arrears; IHI unveils first projects from its applicant-driven call; Eurostat data points to an improvement in the unmet medical needs of children

Inside EU Health

Inside EU Health: Parliament votes on Critical Medicines Act; EMA regulatory co-operation; Paracetamol (still) safe during pregnancy

Parliament votes on Critical Medicines Act position; EMA to build on regulatory co-operation piloted under COVID; Paracetamol is (still) safe during pregnancy

Critical Medicines Act

Parliament draws the battle lines on Europe’s Critical Medicines Act

The European Parliament has overwhelmingly endorsed a more ambitious Critical Medicines Act

Inside EU Health

Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI; ECDC issues warning on Doxy-PEP

Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI principles; ECDC issues warning on Doxy-PEP

EU/US Trade

US tariffs and MFN pricing threaten pharma investment and access in Europe

Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe

Inside EU Health

Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives

🎄Happy Christmas! The Health Package has arrived: Biotech Act, Targeted fix of medical device and; ‘Safe Hearts Plan’

Cardiovascular disease

‘Safe Hearts Plan’ sets out an EU response, but critics see gaps

Critics warn that the EU’s cardiovascular disease plan lacks the strong preventive measures needed to match the scale of the problem

Biotech Act

Europe pushes to regain ground on competitors with new Biotech Act

With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise

Medical devices

EU moves to fix failing medical and in vitro device rules and spur innovation

A 'targeted' revision to the MDR and IVDR promises clearer timelines, proportionate oversight and faster access to innovative technologies

Inside EU Health

Inside EU Health: Parliament pushes for bolder CMA; cardiovascular disease costs 2% EU GDP; EU backs rapid ‘test-before-treat’ diagnostic

Parliament pushes for a more ambitious and European Critical Medicines Act; report estimates that cardiovascular disease costs the EU 2% of GDP; and Commission backs rapid ‘Test Before Treat’ technology to reduce misuse of antibiotics

Critical Medicines Act

Parliament pushes for a more ambitious and European approach to Critical Medicines Act

The European Parliament’s public health committee has endorsed compromise amendments to the Critical Medicines Act, setting out a more ambitious approach than member states

Cardiovascular disease

Cardiovascular disease is estimated to cost the EU 2% of GDP

Ahead of tomorrow’s ‘Safe Hearts Plan’ on cardiovascular disease, the Commission released a report which shows the heavy toll on Europe’s health and its pockets